Towards the elimination of rabies in Eurasia, Paris, 27-30 May 2007 1 Efficacy of a square presentation of V-RG vaccine baits in red fox, domestic dog.

Slides:



Advertisements
Similar presentations
AGVISE Laboratories %Zone or Grid Samples – Northwood laboratory
Advertisements

1 Yell / The Law and Special Education, Second Edition Copyright © 2006 by Pearson Education, Inc. All rights reserved.
1
1 Copyright © 2013 Elsevier Inc. All rights reserved. Appendix 01.
ALGEBRA Number Walls
OPTN Modifications to Heart Allocation Policy Implemented July 12, 2006 Changed the allocation order for medically urgent (Status 1A and 1B) patients Policy.
UNITED NATIONS Shipment Details Report – January 2006.
David Burdett May 11, 2004 Package Binding for WS CDL.
Performance of Hedges & Long Futures Positions in CBOT Corn Goodland, Kansas March 2, 2009 Daniel OBrien, Extension Ag Economist K-State Research and Extension.
Noël TORDO CANINE ADENOVIRUS- BASED VACCINES AGAINST RABIES working together to stop the ongoing tragedy of rabies!
1 Molecular epidemiology of lyssaviruses in Eurasia Dr Lorraine McElhinney Veterinary Laboratories Agency (Weybridge), UK.
IMMUNOGENICITY OF ERA G 333 STRAIN
NEW STEP IN THE CONTROL OF CANINE RABIES IN INDIA 1 HSADL-High Security Animal Disease Laboratory, Indian Veterinary Research Institute, Anand Nagar, Bhopal.
Nicholas Johnson Rabies and Wildlife Zoonoses Group
1 1 FGI Federal Centre for Animal Health, Vladimir, Russia 2 Finnish Food Safety Authority Evira 3 Helsinki University, Helsinki, Finland FINNISH-RUSSIAN.
Academy of Military Medical Science
NATIONAL VETERINARY RESEARCH INSTITUTE, PULAWY, POLAND Towards the Elimination of Rabies in Eurasia, Paris, May 2007 RABIES SURVEILLANCE IN POLAND.
ATTAINING RACCOON RABIES MANAGEMENT GOALS: HISTORY AND CHALLENGES
1 Risk of rabies introduction by non-commercial movement of pets The EFSA Journal (2006) , Assessment of the risk of rabies introduction into the.
Stray dogs and rabies in Bangkok, Thailand
The Rabies Situation in Western Europe Alexander I. Wandeler OLF, CFIA Ottawa, Canada.
SYLVATIC RABIES IN RUSSIA WITH SPECIAL ATTENTION TO PERSPECTIVES OF ORAL VACCINATION OF WILD CARNIVORES A. Botvinkin, D. Bankovsky, G. Safonov Irkutsk.
1 Towards the elimination of Rabies in Eurasia Jean Blancou, WOAH, May
WHO/MZCP RABIES in the MIDDLE EAST A. Seimenis, D.V.M. Director, WHO/Mediterranean Zoonoses Control Centre ATHENS, GREECE
Ministery of Mexico Health
1 RA I Sub-Regional Training Seminar on CLIMAT&CLIMAT TEMP Reporting Casablanca, Morocco, 20 – 22 December 2005 Status of observing programmes in RA I.
Entry task 1) What can be concluded from the following pattern? = 15 = 3 × = 20 = 4 × = 25 =
CALENDAR.
0 - 0.
ADDING INTEGERS 1. POS. + POS. = POS. 2. NEG. + NEG. = NEG. 3. POS. + NEG. OR NEG. + POS. SUBTRACT TAKE SIGN OF BIGGER ABSOLUTE VALUE.
School Shop. Welcome to my shop. You have 10p How much change will you get? 7p 3p change.
1 From the analytical uncertainty to uncertainty in data interpretation D. Concordet, J.P. Braun
Stem Cell Opinion Poll Activity 5.1. STEM CELLS When looking at the opinion polls remember to look at the date and the number of people surveyed.
Break Time Remaining 10:00.
The basics for simulations
PP Test Review Sections 6-1 to 6-6
Gardner A et al. J Clin Oncol 2008:26(35):
Influenza Vaccine Manufacturing
Infectious Bronchitis
Exarte Bezoek aan de Mediacampus Bachelor in de grafische en digitale media April 2014.
15. Oktober Oktober Oktober 2012.
| Slide 1 of 63 April 2007 Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Waterfront.
Copyright © 2012, Elsevier Inc. All rights Reserved. 1 Chapter 7 Modeling Structure with Blocks.
1 RA III - Regional Training Seminar on CLIMAT&CLIMAT TEMP Reporting Buenos Aires, Argentina, 25 – 27 October 2006 Status of observing programmes in RA.
Adding Up In Chunks.
Sets Sets © 2005 Richard A. Medeiros next Patterns.
1 10 pt 15 pt 20 pt 25 pt 5 pt 10 pt 15 pt 20 pt 25 pt 5 pt 10 pt 15 pt 20 pt 25 pt 5 pt 10 pt 15 pt 20 pt 25 pt 5 pt 10 pt 15 pt 20 pt 25 pt 5 pt Synthetic.
+21 Economic Expectations Europe December 2013 Indicator > +20 Indicator 0 to +20 Indicator 0 to -20 Indicator < -20 European Union total: +14 Indicator.
Avian Influenza Surveillance in DKI Jakarta IDP Project Closing Meeting - Bogor, 2 November 2011.
Before Between After.
NORTRIP Different measures to reduce PM10 concentrations –a model sensitivity analysis Gunnar Omstedt, SMHI Introduction model description.
: 3 00.
5 minutes.
1 Let’s Recapitulate. 2 Regular Languages DFAs NFAs Regular Expressions Regular Grammars.
Converting a Fraction to %
Clock will move after 1 minute
HIV and Aging Kathleen K Casey, MD Director, AIDS Ambulatory Care Center Jersey Shore University Medical Center.
Physics for Scientists & Engineers, 3rd Edition
Select a time to count down from the clock above
Murach’s OS/390 and z/OS JCLChapter 16, Slide 1 © 2002, Mike Murach & Associates, Inc.
HPV-vaccines – a breakthrough in medicine Björn Strander Onkologiskt centrum Västra regionen and Kungsbacka Närsjukhus Sweden.
Copyright Tim Morris/St Stephen's School
INTEGRATED RABIES EPIDEMIOLOGY IN REMOTE INUIT COMMUNITIES IN QUÉBEC, CANADA: A “ONE HEALTH” APPROACH C. Aenishaenslin, A. Simon, T. Forde, A. Ravel, J-F.
The Epidemiology of Animal Rabies and Public Health Implications Dr Paul Bartlett MPH., DVM., Ph. D. VM 544 Veterinary Preventive Medicine.
How do you get rabies? You can get the rabies virus from the saliva of a rabid animal – in most cases, by being bitten. Any mammal can get rabies, and.
Dr. Lea Knopf Scientific and Technical Department OIE OIE international standards on Rabies: Regional cooperation towards eradicating the oldest known.
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
THE STORY OF FOX VACCINATION AGAINST RABIES USING A RECOMBINANT VACCINIA-RABIES VIRUS Paul-Pierre PASTORET World Organisation for Animal Health.
Scientific and Technical Department OIE
Presentation transcript:

Towards the elimination of rabies in Eurasia, Paris, May Efficacy of a square presentation of V-RG vaccine baits in red fox, domestic dog and raccoon dogs F. Cliquet 1, A.L. Guiot 2, C. Schumacher 3, J. Maki 3 and J. Barrat 1 1 WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, Community Reference Laboratory for Rabies Serology, AFSSA Malzéville, France 2 Conseils en Pharmacie et Biologie Santé, Lyon, France 3 Merial, Lyon (France) and Athens (USA)

Towards the elimination of rabies in Eurasia, Paris, May V-RG rabies vaccine * V-RG vaccine (Raboral ® V-RG) is a vaccinia virus recombinant coding for the rabies glycoprotein gene. * V-RG vaccine baits have been extensively used in France and in other European countries which are all rabies free (France, 2000 ; Belgium and Luxembourg, 2001) and is currently used in US and also in Ukraine. * This vaccine is one of the two vaccines recognised and recommended by the European Commission (2002) and WHO (2005) for oral vaccination of foxes against rabies. Rectangular Fishmeal polymer bait (France) for red foxes and raccoon dogs (Merial) Square Fishmeal or Chickenmeal Polymer bait (USA) for raccoons, coyotes and gray foxes (Merial)

Towards the elimination of rabies in Eurasia, Paris, May To evaluate in captive animals (domestic dog, red fox and raccoon dog) the efficacy of a square V-RG bait produced in USA in captive animals Evaluation of : Attractiveness of the baits Induction of neutralising antibodies Protection after rabies challenge Objective

Towards the elimination of rabies in Eurasia, Paris, May Experimental design Raccoon dogs vaccinated controls vaccinated controls vaccinated controls square VRG placebo bait square VRG placebo bait square VRG NA TCID 50 /dose TCID 50 /dose TCID 50 /dose - D30 New York rabies strain D91 Salivary gland homogenate from rabid foxes, 400 MIC LD 50 D214 Salivary gland homogenate from a naturally infected coyote (CDC), 1600 MIC LD 50 Dogs Foxes NA : not administered All animals daily observed and kept at least for 90 days after challenge Number of animals DO : VaccinationVaccine titreChallenge

Towards the elimination of rabies in Eurasia, Paris, May Results - Bait acceptability Species Dogs Foxes Raccoon dogs Bait consumption in vaccinatesplacebo Bait uptake time 8/9 1/9 10/10 1/3 2/3 10/10* - less than 1 hour less than 24 hours mean time of disappearance 4.2 hours (SD = 7 hours) * Doubtful for two foxes

Towards the elimination of rabies in Eurasia, Paris, May Results Dogs : rabies virus neutralising antibodies and resistance to challenge S : survive D : die Only one dog out of 9 vaccinates seroconverted All three controls died between D14 and D17 One vaccinate died at D15

Towards the elimination of rabies in Eurasia, Paris, May Results Foxes : rabies virus neutralising antibodies 2 vaccinated foxes did not seroconvert

Towards the elimination of rabies in Eurasia, Paris, May Results Foxes : resistance to challenge Vaccinated Controls Mean mortality delay (days) 14 14,40 Total 10 Rabies diagnosis (FAT + cell culture) 2 pos, 8 neg 10 pos Dead 2 10 Group

Towards the elimination of rabies in Eurasia, Paris, May Results Raccoon dogs : rabies virus neutralising antibodies

Towards the elimination of rabies in Eurasia, Paris, May Vaccinated Controls Mean mortality delay (days) - 18,90 Total 10 9 Rabies diagnosis (FAT + cell culture) 10 neg 9 pos Dead 0 9 Group Results Raccoon dogs : resistance to challenge

Towards the elimination of rabies in Eurasia, Paris, May Discussion - The square fishmeal polymer bait V-RG is well accepted by dogs, foxes and raccoon dogs. - The rate of seroconversion following bait uptake as well as the magnitude of antibody titres are different in the 3 species : 5.38 (4.23) Neutralising antibodies at D28 Dogs (1.09) 2.95 (13.27) 1/9 7/9 10/10Raccoon dogs Foxes min (IU/ml) max (IU/ml) GMT (S.D.) positive/ total The high levels of rabies antibodies observed in raccoon dogs have been also observed when vaccinated with an attenuated oral vaccine (Cliquet and al, 2006)

Towards the elimination of rabies in Eurasia, Paris, May Discussion - The challenge was validated since all controls died from rabies (typical rabies signs were observed and diagnostic tests positive). - Protection after challenge was satisfactory in the three species tested. * Dogs : protection (8/9 dog) despite absence of seroconversion already largely documented. * Foxes : protection in 8/10 foxes ; two vaccinated foxes did not seroconvert and succumbed to rabies challenge. * Raccoon dogs : protection in all vaccinated raccoon dogs.

Towards the elimination of rabies in Eurasia, Paris, May Conclusion - The square fishmeal polymer bait V-RG tested in domestic dogs, foxes and raccoon dogs was attractive, immunogenic and efficient. - The efficacy data support the idea of a potential sourcing of this oral rabies vaccine : for oral vaccination campaigns in those European countries where both foxes and raccoon dogs represent major wildlife species affected by rabies, for oral vaccination of dogs as a complement to other means (parenteral vaccination and ABC programs) in countries where canine rabies is endemic.

Towards the elimination of rabies in Eurasia, Paris, May ACKNOWLEDGMENTS - Chuck Rupprecht (CDC) - Jacqueline Bailly, Michel Munier, Nicolas Penel, Josiane Ambert, Jean-Michel Bousset, Audrey Hamen, Michel Ritleng, Chantal Patron, Patricia Grosgeorge, Anouck Labadie, Estelle Litaize and Sébastien Kempff and Jean Luc Schereffer (AFSSA Nancy)